Nicholas Grund - Chief Commercial Officer at Akebia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
AKBA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Nicholas Grund since 11/4/2023

Holdings reported by Nicholas Grund for Akebia Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 303K $510K $1.68 Jan 31, 2024 Direct
Stock Option (Right to buy) 455K Jan 31, 2024 Direct Common Stock

Transactions reported by Nicholas Grund for Akebia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.